Market Research Reports- Consulting Analysis Crystal Market Research Diabetic Retinopathy Market by Type and Management | Page 2

North America dominated the global diabetic retinopathy market in 2016. This can be attributed to number of
factors such as increasing prevalence of diabetes, high adoption of advanced products, and favorable reimbursement
policies. Asia-Pacific is expected to witness high growth rate, due to high patient population, increasing healthcare
spending, and increased focus of international players on emerging markets owing to growing preference for
advanced healthcare facilities and rising disposable income of people.
Diabetic retinopathy market is highly competitive in nature with the presence of large number of players such as
Bayer AG, F. Hoffmann-La Roche, Allergan plc, Alimera Sciences, Novartis International AG, Pfizer, Regeneron
Pharmaceuticals Inc., Ampio Pharmaceuticals., Abbott Laboratories, and Valeant Pharmaceutical.
Request a sample copy of Diabetic Retinopathy Market Research Report @
http://www.crystalmarketresearch.com/report-sample/HC0622
Key Findings of the Research Study:





Laser surgery segment occupied more than two-fifth of the global market in 2016, due to high adoption of
this technique for the treatment of diabetic retinopathy.
Proliferative retinopathy occupied largest share of the global diabetic retinopathy market in 2016, due to
rising geriatric population rapidly moving towards proliferative stage of retinopathy.
U.S. dominated the NorthAmerica market in 2016, due to high market penetration of drugs such as
Avastinand Eylea.
Europe occupied the second largest share of the global market in 2016. This can be attributed to rise in
diabetic population, high adoption of technologically advanced products, and rise in demand for early
screening techniques.
Asia-Pacific is expected to witness high growth rate during the forecast period due to large diabetic
population base and increasing awareness about diabetes and availability of treatment options.
Inquire more about this report at: http://www.crystalmarketresearch.com/send-an-enquiry/HC0622
Diabetic Retinopathy Market is segmented as follows –
By Type:
 Proliferative Diabetic Retinopathy
 Diabetic Macular Edema
By Management:
 Anti VEGF Drugs
 Steroid Implants